HCD herbs | Major anticancer compounds | Cancer types (cell lines) | Cellular effects | Molecular mechanisms | References |
---|---|---|---|---|---|
Scutellariae Radix | Baicalein, wogonin | Esophageal squamous cell carcinoma (EC-109), glioma (U87MG, U251MG, C6, U251), colon cancer (HCT116), bladder cancer (TSGH8301, BFTC905, RT4, T24, HT1376), breast cancer (T47D, MCF-7, SK-BR-3, MDA-MB-231, SKBR3), leukemia (CEM), pancreatic carcinoma (Colo-357), hepatocellular carcinoma (HepG2, SK-HEP-1), Hodgkin’s lymphoma (L1236), melanoma (SK-MEL-37), nasopharyngeal carcinoma (NPC-TW076, NPC-TW039) | Inhibiting proliferation, invasion, migration and angiogenesis, inducing apoptosis and differentiation | ↓MMP2, ↓MMP9, ↑TIMP1, ↑TIMP2, ↓p38, ↑PI3K/AKT, ↓NF-κB, ↑PPAP γ, ↓CDC2-survivin, ↓Wnt, ↓CDK9, ↓HIF-1α, ↓VEGF, ↑GSK3β/β-catenin, ↓ΔNp63, ↑cleaved PARP, ↑caspase-3, ↑caspase-7, ↑p21 | |
Coptidis Rhizoma | Berberine | Breast cancer (MCF7, MDA-MB-468), gastric cancer (MKN-74), colon cancer (HCT116, SW480, SW620, DLD-1, KM12, KM12SM, KM12L4A,), esophageal cancer (YES-1, YES-2, YES-3, YES-4, YES-5, YES-6), nasopharyngeal carcinoma (5-8F, C666-1), kidney cancer (G401), bladder cancer (T24), hepatocellular carcinoma (HepG2) | Inhibiting proliferation, invasion, migration and angiogenesis, inducing apoptosis, cell cycle arrest at G0/G1 phase and mitochondrial membrane damage, increasing ROS | ↑IFN-β, ↑TNF-α, ↓Cyclin B1, ↓CDC2, ↓Ezrin, ↑p27, ↑p21, ↑Cyclin E, ↑AMPK, ↑WTX, ↓GSK3β/β-catenin, ↓JNK/p38, ↓Wnt, ↓STAT3, ↑caspase-8, ↑caspase-3, ↓Bid, ↑Bax/Bcl-2, ↑Fas, ↑cleaved PARP, ↓NAT, ↓COX-2, ↑TRAIL, ↑VEGF | |
Artemisiae annuae Herba | Artemisinin | Leukemia (HL-60, NB4), ovarian cancer (HO-8910), prostate cancer (LNCaP), breast cancer (MCF-7), nasopharyngeal carcinoma (CNE-1, CNE-2), hepatocellular carcinoma (HepG2, SMMC-7721), melanoma (A375P, A375M), myeloma (RPMI 8226), colon cancer (HCT16), cervical cancer (HeLa, Caski) | Inhibiting proliferation, invasion, migration and angiogenesis, Inducing apoptosis, cell cycle arrest at G1 phase and mitochondrial dysfunction, increasing ROS | ↑MAPKs, ↓p38MAPK, ↓VEGF, ↓KDR, ↓CDK2, ↓CDK4, ↓cyclin E, ↓cyclin D1, ↓E2F1, ↓BMI-1, ↑RKIP, ↓Bcl-2, ↑Bax, ↑caspase-3, ↓IGF-IR, ↓MMP2, ↓TIMP2, ↓αVβ3, ↓NF-κB | |
Hedyotis diffusa | Ursolic acid, methylanthraquinone | Histocytic lymphoma (U937), leukemia (HL-60), colon cancer (HT-29), melanoma (B16-F10), lung cancer (A549), breast cancer (MCF-7), prostate cancer (LNCaP), Tsu-Pr1, MDA-MB-453, DU-145, cervical cancer (C-33A, U14), sarcoma (S180), hepatocellular carcinoma (HepG2, H22, SMMC-7721) | Inhibiting proliferation, migration and angiogenesis, inducing differentiation, apoptosis, cell cycle arrest at G0/G1, S or G2/M phases, DNA fragmentation and mitochondrial dysfunction | ↑interferon-γ, ↑TNF-α, ↑IL-1, ↓NF-κB, ↑Fas, ↑p53, ↑p21/Cip1, ↓p27/kip1, ↑caspase-3, ↑caspase-9, ↑AP-1, ↓Bcl-2, ↑Bax, ↓STAT3, ↓cyclin D, ↓cyclin D1, ↓cyclin D2, ↓cyclin E, ↓CDK4, ↓CDK2, ↓E2F1, ↑Fas-L, ↑TRAIL, ↓MAPK/ERK, ↓JNK, ↑PI3K, ↑p21/WAF1, ↑CDKN1A, ↓cyclin A2, ↓cyclin B1, ↓ODC1, ↓VEGF-α, ↑HSP 70, ↑P16, ↓pim-1, ↓rel, ↓ras, ↓fos, ↓myc, ↑IFN-γ | |
Rabdosiae rubescentis Herba | Oridonin | Hepatocellular carcinoma (HepG2), gallbladder carcinoma (SGC996, NOZ), breast cancer (MCF-7, MDA-MB-231), cervical cancer (HeLa), histiocytic lymphoma (U937), pancreatic cancer (SW1990) | Inhibiting proliferation, migration and invasion, inducing apoptosis, autophagy, DNA damage and cell cycle arrest at S and G2/M phases, increasing ROS | ↑Hsp70-1, ↑STAP, ↑TCTP, ↑Sti1, ↑PPase, ↓hnRNP-1, ↑HP1 β, ↑GlyRS, ↓NF-κB, ↑Bax/Bcl-2, ↑caspase-3, ↑caspase-9, ↑cleaved PARP, ↓IKKα, ↓IKKβ, ↓mTOR, ↑Fas, ↑PPAR-γ, ↓MMP2/MMP9, ↓Integrin β, ↓FAK, ↓Akt, ↓FOXO, ↓GSK3, ↓ERK, ↓IL-1β, ↑Beclin-1, ↑LC3 II/I, ↑Atg4B, ↓p38 MAPK, ↑p53, ↑p21 | |
Scutellariae barbatae Herba | Apigenin, luteolin | Hepatocellular carcinoma (MHCC97H), colon cancer (HT-29), leukemia (LM-1, LM-2), cervical cancer (HeLa) | Inhibiting proliferation and invasion, inducing apoptosis, differentiation and cell cycle arrest at G1 phase | ↓MMP-2, ↓MMP-9, ↑TIMP-1, ↑TIMP-2, ↑ACTA2, ↑Calponin, ↑p27, ↓Cyclin D1, ↓CDK4, ↑p21, ↑Bax/Bcl-2, ↓STAT3, ↓ERK1/2, ↓p38, ↑Smac, ↑Apaf-1, ↑caspase-9, ↑caspase-3, ↓IGF-1, ↑cytochrome c | |
Bupleuri Radix | Saikosaponin D | Cervical cancer (HeLa), breast cancer (MCF-7), prostate cancer (PC3), lung cancer (H1299, LLC-1, A549), hepatocellular carcinoma (HepG2, Hep3B), gastric adenocarcinoma (MK-1), cervical cancer (HeLa), melanoma (B16F10), leukemia (P-388), oral epidermoid carcinoma (KB) | Inhibiting proliferation, invasion, metastasis, and angiogenesis, inducing apoptosis, autophagic cell death, cell cycle arrest at G1, or G2/M phases | ↑ERK1/2, ↑caspase-3, ↑caspase-9, ↑caspase-7, ↑cleaved PARP, ↑AMPK, ↑mTOR, ↑p27, ↓p53, p21/WAF1, ↑Fas/APO-1, ↑mFasL, ↑sFasL, ↑Bax, ↓IKB-α, ↓NF-κB, ↓Bcl-XL, ↓SERCA Ca2+ pump, ↑[Ca2+]i, ↓telomerase, ↑tubulin polymerization | |
Sophorae flavescentis Radix | Matrine | Hepatocellular carcinoma (H22, S180, SMMC-7721, HepG2, Hep-7402), breast cancer (MA737, MKN45, SGC-70901, MDA-MB-231), gastric cancer (SGC-7901), melanoma (A375, SK-MEL-2, M21, B16-F10), cervical cancer (HeLa), leukemia (K-562), glioma (C6), lung cancer (A549, NCI-H460), ovarian cancer (SK-OV-3), central nervous system cancer (XF498), pulmonary adenoma (SPC-A-1), esophagus cancer (Eca-109), colon cancer (SW1116, HCT-15), osteosarcoma (UMR-108, MNNG/HOS), pancreatic cancer (PANC-1), leukmia (U937, HL-60), adenoid cystic carcinoma (ACC-M), retinoblastoma (Y79, WERI-RB1, SO-RB50), nasopharynx cancer (TW03) | Inhibiting proliferation, adhesion, invasion, metastasis and angiogenesis, inducing apoptosis, autophagy, differentiation and cell cycle arrest at G0/G1 or G2 phases, modulating immune function | ↑Beclin 1, ↑Bax, ↓Bcl-2, ↑caspase-8, ↑caspase-3, ↑caspase-9, ↑AKT, ↓NF-κB, ↓IκBα, ↓p65, ↓ERK1/2, ↓JNK, ↓p38 MAPK, ↓TNFαl, ↓IKB-α, ↓p65, ↓ERK1/2, ↑E2F1, ↓Rb, ↑Apaf-1, ↓MMP-9, ↓MMP-2, ↓AKT, ↓EGF, ↓VEGF, ↓VEGF2, ↓VEGFR1, ↑Fas, ↑FasL, ↑p21, ↑p27, ↓Cyclin D1, ↓Cyclin E, ↓hTERT | |
Pulsatillae Radix | Pulsatilla saponin A, D, H | Gastric cancer (MKN-45, MKN-28, AGS), colon cancer (HT-29, LoVo), hepatocellular carcinoma (Huh-7, HepG2) | Inducing DNA damage and apoptosis | ↑Caspase-3, ↑cleaved PARP, ↑Bax, ↓c-Met, ↓AKT, ↓mTOR, ↓p70S6K, ↓HIF-1α, ↓VEGF | |
Cremastrae pseudobulbus, Pleiones pseudobulbus | Colchicine | Hepatocellular carcinoma (HCC24/KMUH, HCC38/KMUH) | Inhibit proliferation interacting with tubulin | ↑AKAP12, ↑TGF-β2, ↑MX1 | |
Belamcandae Rhizoma | Tectorigenin | Hepatocellular carcinoma (HepG2), lung cancer (LLC), sarcoma (S180), prostate cancer (LNCaP) | Inhibiting the proliferation and angiogenesis, inducing apoptosis, differentiation and mitochondrial dysfunction, increasing ROS | ↑Caspase-3, ↑caspase-9, ↓PDEF, ↓PSA, ↓IGF-1, ↑TIMP-3, ↑cytochrome c, ↑[Ca2+]i |